Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Chloe, and I will be your conference operator today.
Posts Tagged ‘NASDAQ:KPTI’
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2024 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2024 Earnings Call Transcript February 19, 2025Karyopharm Therapeutics Inc. beats earnings expectations.
12 Best Penny Stocks to Invest in According to the Media
On December 24, Global Advisors’ managing partner, Tom Lee, shared his thoughts on the potential of small and mid-cap stocks in 2025.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2024 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2024 Earnings Call Transcript November 5, 2024Karyopharm Therapeutics Inc. beats earnings expectations.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
Operator: Good morning. My name is Liz [ph] and I'll be your conference operator today.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript
Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.29.
5 Best Rising Penny Stocks To Buy
Monopar Therapeutics (NASDAQ:MNPR) recently jumped after the company reported positive preclinical data for its MNPR-101 program.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Guru and I will be your conference operator today.
11 Best Biotech Penny Stocks to Buy Now
As investors begin to see light at the end of the tunnel, their risk appetite, which had vanished amid recession risks and volatility, is coming back, creating chances of major...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2023 Earnings Call Transcript
Operator: Good morning. My name is Jason and I will be your conference operator today.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2023 Earnings Call Transcript
Operator: Good morning. My name is Ryan, and I will be your conference operator today.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2022 Earnings Call Transcript
Operator: Good day. My name is Andrea, and I will be your conference operator today.
5 Best Medical Stocks Under $5
In this piece, we will take a look at the five best medical stocks under $5.
Karyopharm Therapeutics Inc (KPTI): Are Hedge Funds Right About This Stock?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Is KPTI A Good Stock To Buy According To Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Karyopharm Therapeutics Inc (KPTI): Hedge Fund Sentiment Unchanged
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Were Hedge Funds Right About Souring On Karyopharm Therapeutics Inc (KPTI)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Karyopharm Therapeutics Inc (KPTI): Hedge Funds Taking Some Chips Off The Table
In this article you are going to find out whether hedge funds think Karyopharm Therapeutics Inc (NASDAQ:KPTI) is a good investment right now.
Were Hedge Funds Right About Karyopharm Therapeutics Inc (KPTI)?
We hate to say this but, we told you so.
Hedge Funds Dropped The Ball On Karyopharm Therapeutics Inc (KPTI)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Did Hedge Funds Drop The Ball On Karyopharm Therapeutics Inc (KPTI)?
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited...
Here’s What Hedge Funds Think About Karyopharm Therapeutics Inc (KPTI)
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as...
Here’s What Hedge Funds Think About Karyopharm Therapeutics Inc (KPTI)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
Karyopharm Therapeutics Inc (KPTI) Hedge Funds Are Snapping Up
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Hedge Fund and Insider Trading News: Ray Dalio, Dan Loeb, Edward Lampert, Select Interior Concepts (SIC), American Financial Group Inc (AFG), Air T, Inc. (AIRT), and More
For new investors, approaching the stock market can be confusing.
Hedge Fund and Insider Trading News: Ray Dalio, Israel Englander, Heartland Express, Inc. (HTLD), Tandy Leather Factory, Inc. (TLF), Solaredge Technologies Inc (SEDG), and More
President Donald Trump's decision Thursday to cancel the Singapore summit with North Korea leader sent the price of gold higher as global investors sought safety.
13G Filing: Point72 Asset Management and Karyopharm Therapeutics Inc. (KPTI)
Please follow Point72 Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its...
Opus Point Partners’ AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
13D Filing: Delphi Ventures VIII LP and Karyopharm Therapeutics Inc. (KPTI)
You can access the original SEC filing by clicking here.
Here’s What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)
The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space.
Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Looking Ahead To The Karyopharm Therapeutics Inc (KPTI) MM Data
Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to report an overview of the topline data from its lead multiple myeloma trial on September 6 and markets are rallying in advance...
Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics
Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses 5.6% of the company's common...
